Dale Fisher

Prof. Dale Fisher

Infectious Disease Division, Department of Medicine, National University Health System, Singapore
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in BMC Medicine
Verified
Journal Article
Open access
PDF file
Dale FisherDale Fisher
Dale Fisher
DHDavid Heymann
David Heymann

11 April 2022 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
RLRyan Ruiyang Ling
Ryan Ruiyang Ling
KRKollengode Ramanathan
Kollengode Ramanathan
FTFelicia Liying Tan
Felicia Liying Tan
TCTAI Bee Choo
TAI Bee Choo
JSJyoti Somani
Jyoti Somani
GMGraeme MacLaren
Graeme MacLaren

1 April 2020 in The Lancet
Verified
Journal Article
Closed access
Dale FisherDale Fisher
Dale Fisher
AWAnnelies Wilder-Smith
Annelies Wilder-Smith

12 May 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
YLYee-Sin LEO
Yee-Sin LEO
TTTun L Thein
Tun L Thein
Dale FisherDale Fisher
Dale Fisher
JLJenny G Low
Jenny G Low
HOHelen M Oh
Helen M Oh
DLDavid C. Lye
David C. Lye
Dengue re-emerges in Singapore despite decades of effective vector control; the infection predominantly afflicts adults. Severe dengue not fulfilling dengue hemorrhagic fever (DHF) criteria according to World Health Organization (WHO) 1997 guideline was increasingly reported. A new WHO 2009 guideline emphasized warning signs and a wider range of severe dengue manifestations. We aim to evaluate the utility of these two guidelines in confirmed adult dengue fatalities.

1 September 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
YMYin Mo
Yin Mo
Dale FisherDale Fisher
Dale Fisher
The Middle East Respiratory Syndrome coronavirus (MERS-CoV) has been a focus of international attention since its identification in 2012. Epidemiologically it is characterized by sporadic community cases, which are amplified by hospital-based outbreaks. Healthcare facilities in 27 countries from most continents have experienced imported cases, with the most significant outbreak involving 186 cases in Korea. The mortality internationally is 36% and guidance for clinical management has yet to be developed. Most facilities and healthcare providers outside of the Middle East receiving patients have no or little experience in the clinical management of MERS. When a case does occur there is likely little time for a critical appraisal of the literature and putative pharmacological options. We identified published literature on the management of both MERS-CoV and the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) through searches of PubMed and WHO and the US CDC websites up to 30 April 2016. A total of 101 publications were retrieved for critical appraisal. Most published literature on therapeutics for MERS are in vitro experiments, animal studies and case reports. Current treatment options for MERS can be categorized as: immunotherapy with virus-specific antibodies in convalescent plasma; polyclonal and monoclonal antibodies produced in vitro or in genetically modified animals; and antiviral agents. The use of any therapeutics in MERS-CoV remains investigational. The therapeutic agents with potential benefits and warranting further investigation include convalescent plasma, interferon-β/ribavirin combination therapy and lopinavir. Corticosteroids, ribavirin monotherapy and mycophenolic acid likely have toxicities that exceed potential benefits.

1 September 2013 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
Dale FisherDale Fisher
Dale Fisher
TSTheresa Seetoh
Theresa Seetoh
HMHelen Oh May-Lin
Helen Oh May-Lin
SVSivakumar Viswanathan
Sivakumar Viswanathan
YTYanling Toh
Yanling Toh
MDMichael Dempsey
Michael Dempsey
Objective.: The primary objective of this study was to validate a novel method of assessing hand hygiene compliance using ultrasound transmitters in patient zones and staff tagged with receivers. The secondary objective was to assess the impact of audio reminders and quantified individual feedback.Design.: An observational comparison against manual assessment followed by assessment using an open-label randomized control method.Setting.: Patient zones were established in 3 wards of 2 large teaching hospitals, including 88 general and 18 intensive care unit ward beds.Participants.: Consented regular ward nursing, medical, and allied health staff.Methods.: Concordance between 40 hours of manual observation using trained hand hygiene auditors and automated measures of opportunities and compliance. Subsequent measured interventions were reminder beeps and written individual feedback.Results.: When compared with manual observations, ultrasound monitoring underestimated percentage compliances by a nonsignificant mean (95% confidence interval [CI]) difference of 5.2% (−20.1% to 9.8%; P = .491). After the intervention, adjusted multivariate analysis showed mean (95% CI) overall compliance in the intervention arm was 6.8% (2.5%−11.1%; P = .002) higher than in the control arm. Results stratified by compliance at entry and exit showed that the effect of intervention was stronger for compliance at exit than at entry.Conclusions.: Our automated measure of hand hygiene compliance is valid when compared with the traditional gold standard of manual observations. As an interventional tool, ultrasound-based automated hand hygiene audits have significant benefit that can be built upon with enhancements and find increasing acceptance with time.